Diagnostic Method for Alzheimer’s from Sweden Becomes International Standard
Researchers at Gothenburg University have developed a reference method for standardized measurements that diagnose Alzheimer’s disease decades before symptoms appear. The method has now formally been classified as the international reference method, which means that it will be used as the standard in Alzheimer’s diagnostics worldwide. Beta amyloid protein is commonly found in the brain. […]
Read MorePreventive Neuroradiology in Brain Aging and Cognitive Decline
A new review published online in American Journal of Neuroradiology highlights the concept that cognitive decline can be identified early and prevented by applying quantitative brain imaging techniques. [More]
Read MoreSense of Smell May Predict Risk for Cognitive Decline
Two studies presented at the 2014 Alzheimer’s Association International Conference (AICC) in Copenhagen this month demonstrated that a decrease in the ability to identify odors was significantly associated with loss of brain cell function and progression to Alzheimer’s disease. There is growing evidence that the decreased ability to correctly identify odors is a predictor of cognitive impairment and an […]
Read MoreFamily history of Alzheimer’s doubles risk
Relatives of people with Alzheimer’s disease are more than twice as likely to develop abnormal brain pathology associated with the condition compared with individuals who don’t have a family history of the disease, a recent study in PLOS ONE said. [More…]
Read MoreFirst Guidelines for Amyloid Imaging in Alzheimer’s Released
Published today, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer’s Association have jointly published the first criteria for the appropriate use of this imaging technology to aid in the diagnosis of people with suspected Alzheimer’s disease. Recently has it become possible to create high-quality images of the brain plaques characteristic of […]
Read MoreNew Recommendations for Cognitive Screening from the Alzheimer’s Association
The Alzheimer’s Association has published new guidelines to provide primary care physicians with guidance on cognitive assessment during an annual wellness visit. An expert workgroup assembled by the association, offers new comprehensive guidance on how to assess for cognitive impairment in the primary care setting. The Alzheimer’s Association points out that “while physicians are required […]
Read MoreDiabetes as a Risk Factor for Dementia
A new study published in the Internal Medicine Journal, examined the association of diabetes with the onset of dementia (including Alzheimer’s disease (AD), vascular dementia (VD) and any dementia) and mild cognitive impairment (MCI). A meta-analysis of longitudinal studies that examined the relationship between diabetes and the onset of dementia or MCI were included. Nineteen […]
Read More